Opus Point Partners Management, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.6%.

Quarter-by-quarter ownership
Opus Point Partners Management, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$240,000
-25.9%
4,8060.0%0.36%
-19.1%
Q1 2019$324,000
+37.3%
4,806
-6.0%
0.44%
-15.4%
Q4 2018$236,000
-79.7%
5,115
-66.1%
0.52%
-81.3%
Q3 2018$1,165,000
-12.7%
15,102
-4.6%
2.78%
-3.9%
Q2 2018$1,334,000
+1.9%
15,833
-1.1%
2.89%
+12.7%
Q1 2018$1,309,000
-20.2%
16,002
-44.3%
2.57%
+80.9%
Q4 2017$1,641,000
-26.3%
28,704
-13.9%
1.42%
-28.9%
Q3 2017$2,226,000
+46.7%
33,347
+13.1%
2.00%
+43.7%
Q2 2017$1,517,000
-54.8%
29,482
-48.6%
1.39%
-44.2%
Q1 2017$3,353,000
+44.7%
57,410
+3.4%
2.49%
+34.8%
Q4 2016$2,317,000
-19.8%
55,524
+1.5%
1.85%
+14.0%
Q3 2016$2,889,000
+59.3%
54,692
+26.3%
1.62%
-7.5%
Q2 2016$1,814,000
-12.4%
43,295
-15.1%
1.75%
+9.4%
Q1 2016$2,071,000
-6.2%
51,000
+50.0%
1.60%
+9.8%
Q4 2015$2,207,000
-32.0%
34,000
-26.1%
1.46%
-18.7%
Q3 2015$3,247,000
+587.9%
46,000
+820.0%
1.79%
+352.8%
Q1 2015$472,000
-4.6%
5,000
+13.2%
0.40%
-19.2%
Q4 2014$495,0004,4160.49%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,930,369$118,428,00083.56%
Third Rock Ventures, LLC 3,070,090$188,350,00021.97%
Opaleye Management Inc. 113,500$6,963,225,0005.43%
BB BIOTECH AG 1,890,521$115,983,0004.72%
Eventide Asset Management 431,600$26,479,0003.70%
Atika Capital Management LLC 54,000$3,313,0002.55%
Cormorant Asset Management, LP 100,000$6,135,0001.26%
BRIDGER MANAGEMENT, LLC 220,099$13,503,0000.92%
Ghost Tree Capital, LLC 20,000$1,227,0000.67%
HAMILTON LANE ADVISORS LLC 27,544$1,690,0000.55%
View complete list of AGIOS PHARMACEUTICALS INC shareholders